Garret A. FitzGerald, MD, FRS
Principal Investigator
garret@upenn.edu
Dr. FitzGerald has overall responsibility for the administrative guidance of the program, its structural coherence and integration and scientific direction. Dr. FitzGerald’s scientific interests are in bioactive lipids and molecular clocks. His work ranges from the use of cellular and animal model systems through detailed study of disease mechanism and drug action in humans to involvement in epidemiological analyses and randomized clinical trials. He serves as the founding Director of the Institute for Translational Medicine and Therapeutics (ITMAT) which anticipated the CTSA program and he served as Chair of the Department of Systems Pharmacology and Translational Therapeutics from 1996-2018. He is a senior advisor to Calico Laboratories.